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Abstract
Background: The use of large amounts of human multipotent mesenchymal stroma/stem cells (MSC) for cell
therapies represents a desirable property in tissue engineering and banking in the field of regenerative medicine.
Methods and results: Whereas cryo-storage of umbilical cord (UC) tissue pieces in liquid nitrogen without
ingredients was associated with predominant appearance of apoptotic cells after thawing and re-culture,
progressive growth of MSC was observed following use of cryo-medium. Moreover, conditioning of UC tissue
pieces by initial explant culture and subsequent cryo-storage with cryo-medium accelerated a further MSC culture
after thawing. These findings suggested that conditioning of UC tissue pieces provides an in vitro stem cell niche
by maintenance of a 3-dimensional natural microenvironment for continuous MSC outgrowth and expansion.
Indeed, culture of GFP-labeled UC tissue pieces was accompanied by increased outgrowth of GFP-labeled cells
which was accelerated in conditioned UC tissue after cryo-storage. Moreover, cryopreserved conditioned UC tissue
pieces in cryo-medium after thawing and explant culture could be cryopreserved again demonstrating renewed
MSC outgrowth after repeated thawing with similar population doublings compared to the initial explant culture.
Flow cytometry analysis of outgrowing cells revealed expression of the typical MSC markers CD73, CD90, and
CD105. Furthermore, these cells demonstrated little if any senescence and cultures revealed stem cell-like
characteristics by differentiation along the adipogenic, chondrogenic and osteogenic lineages.
Conclusions: Expression of MSC markers was maintained for at least 10 freeze/thaw/explant culture cycles
demonstrating that repeated cryopreservation of conditioned UC tissue pieces provided a reproducible and
enriched stem cell source.
Keywords: Mesenchymal stroma/stem cells, Tissue conditioning, Umbilical cord tissue, Cryopreservation, Tissue
engineering, Three-dimensional long-term culture
Background
Mesenchymal stroma/stem cells (MSC) are recruited
towards tissue injuries to exhibit repair, immune modu-
lation, neovascularization, and differentiation capacity
for support of tissue regeneration. Transplantation of
MSCs for substitution of damaged cells or tissue as well
as MSC expansion for tissue engineering in the field of
regenerative medicine require appropriate cell sources
which are provided by invasive collection of bone
marrow-derived MSC [1] or adipose tissue-derived
MSC [2] from appropriate biopsies. Alternatively, more
easily accessible, noninvasive, and therefore ethically
noncontroversial MSC sources are represented by neo-
natal tissues, including MSC from placenta or from um-
bilical cord (UC) [3, 4]. Previous studies revealed the
advantages of explant cultures from human UC to
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obtain large quantities of human UC-MSC with long-
term maintenance of stem cell properties [5].
Human MSC are characterized as a multipotent het-
erogeneous cell population which can be found in nearly
all vascularized organs and tissues. The stem cell proper-
ties include self-renewal and regenerative potential [6].
Certain heterogeneity both in morphology and cell fate as
demonstrated by isolation of MSC subpopulations [7] may
result partially from interaction with neighboring cells in
the cellular microenvironment, from altered trophic fac-
tors, pH, hypoxic conditions, or oxidative stress and pro-
vide difficulties in MSC characterization. Additional
heterogeneous and even controversial findings provided a
discussion platform for a clear description and definition
of MSC [8]. Consequently, instead of a certain specific
cell marker, a broad spectrum of simultaneous minimal
criteria has been identified for MSC, including the cap-
ability for plastic adherence, paralleled by expression of
the CD73, CD90, and CD105 surface molecules with con-
comitant absence of other cell type-specific markers such
as CD14, CD31, CD34, CD45, and human leukocyte anti-
gen DR (HLA-DR) [9, 10]. Furthermore, MSC exhibit
migratory activities [11] and display at least a tri-lineage
differentiation capacity along the osteogenic, chondro-
genic, and adipogenic phenotype [9] whereby also trans-
germline maturation pathways have been discussed. The
differentiation potential of MSC together with immune-
modulatory functions and an involvement in neovasculari-
zation represent multipotent cellular functionalities which
are required for the use in regenerative medicine. MSC
have thus been successfully applied in a variety of clinical
trials – for example, large bone defects [12], cartilage
lesions and traumatic articular cartilage defects [13],
osteogenesis imperfecta [14], graft versus host disease [15],
spinal cord injuries [16], cardiovascular diseases [17], and
hematological pathologies [18] – indicating the need for
large quantities of MSC.
A reproducible source for healthy stem cells including
MSC could be represented by appropriately cryopre-
served tissue. Previous work has demonstrated that cryo-
preservation of birth-associated tissues such as placenta
and UC can serve for hematopoietic stem cells
and MSC, respectively [19, 20]. Moreover, MSC can
also be obtained after cryostorage of whole adipose tis-
sue [21]. Several other studies using different fertility
preservation strategies included embryo cryopreserva-
tion, oocyte vitrification, and ovarian tissue cryostorage
[22]. In addition, counteracting certain mechanisms of
post-thaw cell death could increase the quality of cryo-
preserved tissue [23]. In the present work, we demon-
strate that conditioning of UC tissue pieces can
minimize post-thaw cell death and serves as a reprodu-
cible MSC source and as a valuable three-dimensional
storage compartment for repeatable cryopreservation
and maintenance of MSC within their natural
microenvironment.
Materials and methods
Cell and tissue culture of human UC and MSCs
The use of primary human MSC following explant cul-
ture from UC tissue was approved by the Ethics Com-
mittee of Hannover Medical School (Project #443) on 26
February 2009. Informed written consent was obtained
from each patient.
MSC-like cells were isolated from human UCs as
reported previously [5]. The cells were obtained from
UC explant cultures of three different patients following
delivery of full-term (38–40 weeks) infants either spon-
taneously or by Cesarean section. In brief, UC tissue was
washed with phosphate buffer saline (PBS) to remove
blood cells, cut into approximately 0.5 cm3 large pieces,
and incubated in alpha-minimum essential medium
(αMEM; Sigma Chemie GmbH, Steinheim, Germany)
supplemented with 15 % allogeneic human AB-serum
(HS; commercially obtained from blood bank, University
Campus Lübeck, Germany), 100 U/ml penicillin, 100 μg/
ml streptomycin, and 2 mM L-glutamine (Sigma) at 37 °C
in a humidified atmosphere with 5 % carbon dioxide. After
about 14 days of explant culture with fresh medium re-
placement every 3–4 days, the UC tissue pieces were
removed and the adherent cells were harvested by
accutase (Sigma) treatment for 3 minutes at 37 °C. The
obtained cell suspension was centrifuged at 320 × g for 5
minutes and the cells were resuspended in MSC culture
medium (αMEM supplemented with 10 % HS, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 2 mM L-glutamine)
and subcultured in the appropriate passage.
The UC tissue pieces after initial explant culture were
termed “conditioned” UC tissue. Conditioned tissue has
been cultured for approximately 2 weeks allowing adap-
tation to the culture conditions in contrast to freshly
prepared tissue. Cryopreservation of UC tissue was per-
formed in cryomedium (90 % HS containing 10 % (v/v)
dimethyl sulfoxide (DMSO)) with a freezing velocity of
approximately 1 °C/minute (Nalgene Cryo 1 °C freezing
container; Nunc: Wiesbaden, Germany) until the sam-
ples reached –80 °C. Thereafter, the cryopreserved UC
tissues were stored in liquid nitrogen for 3 days until
start of the next explant culture.
Green fluorescent protein (GFP) labeling of UC tissue
pieces was performed by lentiviral transduction. Six UC
tissue pieces of similar size were transduced with a
third-generation lentiviral SIN vector containing the
eGFP gene according to a labeling technique described
previously for the transduction of MSCs [24]. Briefly,
each of the six UC tissue pieces was separately centri-
fuged together with the lentivirus at 2000 × g/30
minutes, washed three times in MSC culture medium,
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and incubated in one well of a 24-well plate with 500 μl
MSC medium. Fluorescence was measured at 480 nm
excitation/520 nm emission wavelength using a Fluoros-
kan Ascent FL (Thermo Scientific, Waltham, MA, USA)
after transfer of the labeled UC tissue pieces into one
well of a 96-well microtiter plate, respectively. Following
fluorescence measurement, the labeled UC tissue pieces
were cultured further in the 24-well plates.
Reverse transcription PCR analysis
Total RNA was extracted using the RNeasy Mini Kit
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions and reverse transcription RT-PCR was
performed as described previously [25]. As a template, 2.5
μl cDNA was used with primers specific for CD73 (sense,
5′-CGC AAC AAT GGC ACA ATT AC-3′; antisense,
5′-CTC GAC ACT TGG TGC AAA GA-3′; amplifica-
tion product 241 base pairs (bp)), CD90 (sense, 5′-GGA
CTG AGA TCC CAG AAC CA-3′; antisense, 5′-ACG
AAG GCT CTG GTC CAC TA-3′; amplification product
124 bp), CD105 (sense, 5′-TGT CTC ACT TCA TGC
CTC CAG CT-3′; antisense, 5′-AGG CTG TCC ATG
TTG AGG CAG T-3′; amplification product 378 bp), and
eGFP (sense, 5′-CTA TAT CAT GGC CGA CAA GCA
GA-3′; antisense, 5′-GGA CTG GGT GCT CAG GTA
GTG G-3′; amplification product 165 bp). As a control,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
PCR (sense, 5′-ACC ACA GTC CAT GCC ATC AC-3′;
antisense, 5′-TCC ACC ACC CTG TTG CTG TA-3′;
amplification product 452 bp) was performed (all primers
customized by Eurofins, MWG GmbH, Ebersberg,
Germany). Aliquots of 25 μl of each RT-PCR product
were separated on a 2 % agarose gel including the stand-
ard GeneRuler 100 bp DNA Ladder (Thermo Scientific)
and visualized by GelRed™ (Biotium Inc., Hayward, CA,
USA) staining.
Cell cycle analysis
The cell cycle analysis in the different MSC populations
was performed as described previously [26]. Briefly, 5 ×
105 cells were fixed in 70 % (v/v) ice-cold ethanol at 4 °C
for 24 hours. The fixed cells were stained with the CyStain
DNA 2 step kit (Partec GmbH, Münster, Germany) and
filtered through a 50 μm filter. Thereafter, samples were
analyzed in a Galaxy flow cytometer (Partec) using the
FloMax analysis software (Partec).
Senescence-associated β-galactosidase assay
Cell senescence can be detected by different expression
levels of senescence-associated β-galactosidase (SA-β-gal)
[27]. The amount of senescent cells was determined using
the SA-β-gal staining kit (Cell Signaling Technology,
Danvers, Massachusetts, USA) and 4′,6-diamidine-2′-
phenylindoldihydrochloride (DAPI; Roche Diagnostics
GmbH, Mannheim, Germany) fluorescence counterstain
in accordance with the manufacturer’s instructions. For
this purpose, about 4000 cells/cm2 were cultivated for 48
hours in the corresponding media before fixation and SA-
β-gal staining. After completion of the staining procedure,
four representative images were taken from diverse areas
of each cell culture using phase-contrast microscopy and
CellB Imaging Software (Olympus GmbH, Hamburg,
Germany). For the calculation of the percentage of senes-
cent cells, the total number of cell nuclei and the number
of cell nuclei surrounded by cyan dye were enumerated.
Analysis of surface markers by flow cytometry
Characterization of the MSC immunophenotype was per-
formed as described previously [7]. Continuously proliferat-
ing MSC were harvested and analyzed for cell surface
marker expression by flow cytometry. After blocking non-
specific binding to Fc-receptors by incubation of 106 cells
with 2 % fetal calf serum (FCS) for 15 minutes at 4 °C and
washing with PBS–bovine serum albumin (BSA), the cells
were incubated with the following appropriately-labeled
monoclonal anti-human antibodies: CD73-phycoerythrin
(PE) (clone AD2; BD Bioscience, Heidelberg, Germany),
CD90-PE (clone 5E10, IgG1; BioLegend Inc., San Diego,
CA, USA), CD105-PE (clone 43A3, IgG1; BioLegend Inc.),
CD14-fluorescein isothiocyanate (FITC) (clone TÜK4,
IgG2a; MACS, Miltenyi, Bergisch-Gladbach, Germany),
CD31-FITC (clone WM59, IgG1; DAKO, Hamburg,
Germany), CD34-PE (clone AC136, IgG2a; DAKO), and
CD45-FITC (clone T29/33, IgG1; DAKO). Following anti-
body staining, all samples were washed twice with PBS–
BSA. Positive staining was obtained according to control
measurements of the different populations with isotype-
matching IgG control antibodies. Flow cytometry analysis
and histograms were performed in a Galaxy FACSan
(Partec) using FloMax analysis software (Partec).
Cell differentiation
Osteogenesis was induced by maintaining confluent cell
cultures in Dulbecco’s modified Eagle’s medium (DMEM:
Dulbecco's Modified Eagles's Medium)/F12 supplemented
with 0.15 mM ascorbat-2-phosphate, 0.1 μM dexametha-
sone, 3 mM β-glycerol, 10 % fetal bovine serum (FBS;
Biochrom, Berlin, Germany), and 1 % penicillin–strepto-
mycin for 4 weeks. Differentiation was visualized by light
microscopy and Alizarin red staining.
For adipogenic differentiation the different MSC cul-
tures were first grown to confluence and then cultured in
the appropriate differentiation medium (DMEM/F12 with
L-glutamine (PAA, Cölbe, Germany) with 10 % FBS, 1 %
penicillin–streptomycin, 0.15 mM ascorbat-2-phosphate,
1 μM dexamethasone, 0.5 mM 3-isobutyl-1-methylxan-
thine, 0.1 mM indomethacin, and 4 U/l insulin (Aventis,
Frankfurt, Germany)) for 14 days, respectively. The
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maturity of an adipocyte phenotype was evaluated by light
microscopy and oil red O staining.
For chondrogenic differentiation, cells were kept in
pellet culture after centrifugation at 300 × g for 5 mi-
nutes. The cultures were cultivated in DMEM/F12 sup-
plemented with 0.15 mM ascorbat-2-phosphate, 1 %
insulin, transferrin, selenium, ethanolamine solution
(ITS-X; Life Technologies, Darmstadt, Germany), 100
mM sodium pyruvate (Biochrom), 0.1 μM dexametha-
sone, 0.35 mM proline, and 10 ng/ml TGFβ1 (Peprotec,
Rocky Hill, NJ, USA) for 3 weeks. Afterwards, the pellets
were rinsed twice in PBS and fixed in 4 % formaldehyde
in PBS, embedded in paraffin, and cut into sections of 5
μm thickness. The sections were stained with alcian blue
for detection of glycosaminoglycans.
Results
Direct cryopreservation of freshly prepared UC tissue
pieces in liquid nitrogen without cryomedium and a fol-
lowing reculture in MSC medium was associated with
the production of viscous material in the supernatant
and appearance of debris and dead cells within 14 days
(Fig. 1a, upper panel). Supportive evidence was obtained
by cell cycle analysis of this culture demonstrating pre-
dominantly DNA fragments in the sub-G1 phase as an
indication for cell death (Fig. 1b, upper panel). In con-
trast, reculture of UC tissue pieces previously cryopre-
served in the presence of cryomedium revealed the
initial production of viscous material and the outgrowth
of MSC-like cells after 14 days (Fig. 1a, bottom panel),
which was paralleled by a cell cycle of a proliferating
population demonstrating cells in G0/G1, S, and G2/M
phases (Fig. 1b, bottom panel).
Alternatively, direct explant culture of freshly prepared
UC tissue for about 20 days was accompanied by initial
outgrowth of MSC-like cells, whereby the UC tissue be-
came “conditioned”. Liquid nitrogen cryopreservation of
these conditioned UC tissue pieces with cryomedium
followed by reculture exhibited an outgrowth of viable
MSC-like cell populations already within 8 days (Fig. 1c,
upper panel), whereby the first cells were observed
within 2 days of reculture. These differences demon-
strated that the outgrowth of cells from the conditioned
UC tissues starts immediately after reculture, in contrast
to freshly prepared UC tissue still requiring adaptation to
the culture conditions. Moreover, a second cryopreserva-
tion of these recultured conditioned UC100314 tissue
pieces in liquid nitrogen and another second reculture
(UC100314-Re) was accompanied by a similar outgrowth
of MSC-like cells within 14 days (Fig. 1c, bottom panel).
These findings underscored the use of cryomedium for
tissue preservation and suggested that the process of UC
tissue conditioning involved an intratissue remodeling to
enable growth stimulation with protection of the new
cells. Histochemical analysis after hematoxylin and eosin
staining of UC tissue confirmed morphological changes
by a marked condensation of the vessels and the con-
nective tissue within the UC after 14 days of condition-
ing and in recultured UC tissue after cryopreservation as
compared with fresh UC tissue (Fig. 2a).
The expression of MSC characteristic genes was also
observed in the UC tissue pieces under the different
conditions. RNA from fresh UC tissue as well as 14-day
conditioned UC tissue or conditioned UC tissue after
cryopreservation and reculture demonstrated transcripts
for CD73, CD90, and CD105 (Fig. 2b).
The conditioning of UC tissue was investigated in six
UC tissue pieces of approximately similar size and
weight which were cultured for up to 19 days with prior
GFP labeling of tissue-associated cells via lentiviral
transduction. During this explant culture, progressively
increasing GFP fluorescence intensities of the tissue
pieces by 3.4 ± 1.7-fold (n = 6; p <0.05) were measured
(Fig. 2c). Previous work has demonstrated that the GFP
fluorescence intensities corresponded to an appropriate
cell number [24]. Consequently, conditioning of UC tis-
sue was associated with a significant increase of prolifer-
ating cells within the tissue. To further address this
hypothesis, six conditioned UC tissue pieces after cryo-
preservation were recultured and similarly GFP labeled.
The conditioned tissue pieces were more round-shaped
(Fig. 2d) compared with the initial freshly prepared tis-
sue as observed previously [5]. Already within 7 days of
explant culture the fluorescence intensity of the condi-
tioned tissue pieces increased by 11.0 ± 5.1-fold (n = 6: p
<0.005), which substantiated enhanced and accelerated
cell growth after tissue conditioning (Fig. 2d) as com-
pared with the initial fresh culture that took about 19
days with a much lower fluorescence intensity (Fig. 2c).
Following 21 days of explant culture, quantification
and phenotyping of the outgrowing cells from 5.2 mg
GFP-transduced UC tissue were performed by flow cy-
tometry analysis. A total yield of 1.2 × 105 cells con-
tained about 6 % of GFP-positive cells (Fig. 3a, left
panel). Flow cytometry evaluation of the MSC-typical
markers CD73, CD90, and CD105 always revealed in
total more than 98 % positive cells, whereby about 93–
94 % exhibited a PE signal of the unlabeled cells. The
remaining about 5–6 % reflected the outgrowing cells
with a double fluorescence of PE and GFP (detected by
the FITC channel) in accordance with the transduced
population (Fig. 3a, right panel).
A direct comparison between fresh and conditioned
UC tissue substantiated an advantage of the conditioning
whereby all outgrowing cells from both tissues expressed
the MSC-typical markers CD73, CD90, and CD105
(Fig. 3b). A 13-day explant culture revealed about 1.2 ×
103 cells/mg fresh UC tissue (Fig. 3b, left panel) whereas
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prior conditioning yielded about 5.8 × 104 cells/mg con-
ditioned tissue (Fig. 3b, right panel).
Together, these findings demonstrated that cells in-
cluding GFP-labeled populations are proliferating within
the UC tissue during conditioning. Consequently, condi-
tioned UC tissue represented an accelerated initial out-
growth during explant culture whereby explanted cells
exhibit MSC-like properties.
Cells obtained after reculture of conditioned and cryo-
preserved UC tissues from three individual donors were
further analyzed for stem cell characteristics including pro-
liferative capacity, expression of MSC markers, and differ-
entiation potential along mesenchymal lineages. The three
primary cultures MSC100314UC-re(1), MSC110314UC-re(1),
and MSC180314UC-re(1), obtained from corresponding
cryopreserved and recultured UC tissues, respectively,
exhibited significant proliferative activity (Fig. 4a). More-
over, cells from the second reculture after repeated
cryopreservation of the same tissues (MSC100314UC-re(2),
MSC110314UC-re(2), MSC180314UC-re(2)) demonstrated
similar cell growth potential compared with the explant
cultures from the first UC reculture (Fig. 4a). Likewise,
all six populations revealed continuous cell cycle pro-
gression and little if any differences were detectable in
the pattern and distribution of cell cycle phases be-
tween cell populations from the first or the second
reculture of UC tissues (Fig. 4b). These data pointed to
a constant growth capacity of cells irrespective of one
or two freezing cycles of the originating conditioned
tissue. Further support was obtained by the measure-
ment of SA-β-gal, with less than 2 % of positive cells
in all cultures indicating that even after the second
Fig. 1 Morphology and cell cycle properties of recultured UC tissue. a Cryopreserved pure UC290115 tissue pieces in liquid nitrogen without
cryobuffer or any other additives (upper panel) and in the presence of cryobuffer (lower panel) were recultured in MSC medium for 14 days and
the morphology of potential MSC was documented (magnification bars = 100 μm). b Potential MSC from 14-day explant cultures of recultured
and previously cryopreserved UC290115 tissue pieces in liquid nitrogen without cryobuffer (upper panel) and in the presence of cryobuffer (lower
panel) were harvested and subjected to cell cycle analysis. Distribution within sub-G1, G0/G1, S, and G2/M cell cycle phases was performed by
FloMax cell cycle software. c Reculture of conditioned UC100314re(1) tissue pieces after cryopreservation in liquid nitrogen with cryobuffer revealed
the outgrowth of MSC-like cells (MSC100314UC-re(1)) within 8 days (upper panel). In addition, a second reculture after repeated cryopreservation of
these UC tissue pieces (UC100314 re(2)) demonstrated an explant culture of MSC-like cells (MSC100314 UC-re(2)) within 14 days (magnification bars
= 100 μm). MSC mesenchymal stroma/stem cells
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reculture of cryopreserved conditioned UC tissue a ma-
jority of outgrowing juvenile and proliferative active
cells prevailed (Fig. 4c).
MSC characteristics in these explant populations were
evaluated by the presence of CD73, CD90, and CD105,
respectively. Flow cytometry analysis demonstrated al-
ways more than 90 % of these MSC-associated surface
markers in MSC100314UC-re(1), MSC110314UC-re(1), and
MSC180314UC-re(1), as well as in corresponding cell
populations derived from reculture of the second cryo-
preservation (MSC100314UC-re(2), MSC110314UC-re(2),
MSC180314UC-re(2)) (Fig. 5), respectively. These findings
were paralleled by little if any detectable CD14, CD31,
CD34, or CD45 surface markers in either population
(Fig. 5), further substantiating the outgrowth of MSC-
like cells in the explant cultures.
Stem cell properties of MSC also include the capability
to differentiate at least along the osteogenic, adipogenic,
Fig. 2 Histochemical analysis of fresh and conditioned UC. a. Tissue section (4 μm) of hematoxylin and eosin-stained fresh UC tissue (left panel)
was compared with conditioned UC tissue following a 14-day explant culture (middle panel) and with frozen conditioned UC tissue after thawing
and reculture (right panel). b Expression of MSC markers in UC tissue pieces. mRNA from UC tissue pieces at different conditions (fresh
UC, conditioned UC, and frozen conditioned UC after reculture) was analyzed by RT-PCR for transcripts of the MSC markers CD73, CD90,
and CD105 with GAPDH expression as a control. c Proliferation of MSCs in fresh UC tissue pieces during conditioning. UC tissue pieces of
similar size and weight (graph insert) prepared directly after delivery were labeled by lentiviral eGFP gene transduction. Thereafter, the UC
tissues were incubated in MSC medium for up to 19 days and the GFP fluorescence intensity in the tissues was monitored at the time points indicated.
Data represent the mean ± standard deviation (SD) (n = 6). Statistical analysis was performed by Student's t test between the fluorescence intensities of
the unlabeled UC tissues (autofluorescence of the tissues = control) and after eGFP gene transduction (p <0.001). Moreover, statistical differences
between the fluorescence intensities of day 1 and day 19 revealed a significance of p <0.05. d Proliferation of MSC in cryopreserved UC tissue pieces
after reculture. UC tissue pieces of similar size and weight (graph insert) from conditioned UC tissue pieces after cryopreservation and reculture were
labeled by lentiviral eGFP gene transduction. Thereafter, the UC tissues were incubated in MSC medium for up to 7 days and the GFP
fluorescence intensity in the tissues was monitored every 24 hours. Data represent the mean ± SD (n= 6). Statistical analysis was performed by Student's t
test between the fluorescence intensities of the unlabeled UC tissues (autofluorescence of the tissues = control) and after the second day of eGFP gene
transduction (p <0.1). Moreover, statistical differences between the fluorescence intensities of day 1 and day 7 revealed a significance of p <0.005. bp base
pairs, GFP green fluorescent protein
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and chondrogenic lineage. Induction of this tri-lineage
maturation revealed strong similarities in the
differentiation potential of the MSC100314UC-re(1),
MSC110314UC-re(1), and MSC180314UC-re(1) explant
cultures and from the second reculture after repeated
cryopreservation (MSC100314UC-re(2), (Fig. 6). Thus,
mineralization of the explant cultures assayed by Ali-
zarin red staining demonstrated osteogenic potency in
contrast to undifferentiated controls (Fig. 6, left panels).
Moreover, adipogenic potential is usually demonstrated
by increased lipid metabolism associated with the for-
mation of intracellular lipid droplets stained with oil
red O which could be observed exclusively in the adi-
pogenic differentiation-induced explant populations
(Fig. 6, middle panels). A variety of sulfated proteogly-
can deposits are properties of functional chondrocytes
which can be determined by alcian blue, and signifi-
cantly enhanced staining was detected in the differenti-
ated cultures compared with the undifferentiated
controls (Fig. 6, right panels).
Maintenance of MSC stemness by repeated freeze/
thaw/explant culture cycles of UC tissue revealed an un-
altered cell morphology (data not shown). Moreover, all
cultures demonstrated consecutive expression of the
MSC-specific markers CD73, CD90, and CD105 starting
from the first explant culture during conditioning of
MSC tissue until the 10th cryopreservation of the same
UC tissue with subsequent thawing and explant recul-
ture (MSCUC-re(10)) (Fig. 7a). These findings were also
substantiated by flow cytometry analysis demonstrating
expression of CD73, CD90, and CD105 in more than 90 %
of selective populations every third freeze/thaw/explant
Fig. 3 Cell yield and surface marker analysis of explants from GFP-labeled UC tissues. a Quantification of total cell number and GFP-positive cells
after explant culture of GFP-labeled UC tissue was performed by flow cytometry (upper panel). The outgrowing cells after 21 days were analyzed
for the PE-labeled MSC-specific markers CD73, CD90, and CD105, demonstrating the amount of PE-positive unlabeled cells and the appropriate
amount of antibody-positive and GFP-positive cells within the double fluorescence channel, respectively (lower panel). b Comparison of the
amount of outgrowing cells with the MSC-like characteristic surface marker expression CD73, CD90, and CD105 from fresh (upper panel) and
conditioned (lower panel) UC tissue was quantified after 13 days of explant culture and calculated as cell yield per milligram of tissue. FACS
fluorescence-activated cell sorting, FITC fluorescein isothiocyanate, GFP green fluorescent protein, PE phycoerythrin
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culture cycle, respectively (Fig. 7b). The proliferative
capacity of these MSC from conditioned UC tissues
after one, four, seven, and 10 freeze/thaw/explant cul-
ture cycles revealed little if any differences between one
and four freeze/thaw/explant culture cycles; however,
seven and 10 freeze/thaw/explant culture cycles were
associated with a significantly reduced proliferative cap-
acity (Fig. 7c). These findings were substantiated by de-
termination of the MSC yield from consecutive 10-day
UC tissue explant cultures demonstrating a progressive
decrease of outgrowing MSC after six freeze/thaw/ex-
plant culture cycles (Fig. 7a). The data demonstrated an
accumulated yield of about 3.3 × 107 MSC from 5.2 mg
UC tissue within 10 days. Based on an average UC
length of 50–60 cm with 1.5–2 cm diameter and 41 g
weight, an optimal primary explant culture using the
whole UC tissue could initially yield about 2.6 × 1011
MSC. In the case of fresh UC tissue, conditioning
Fig. 4 Proliferative capacity of conditioned UC tissue-derived cells. a Proliferation of MSC-like cells obtained after reculture of cryopreserved conditioned
UC tissues from three different donors (MSC100314UC-re(1), MSC110314UC-re(1), MSC180314UC-re(1)) was evaluated by cell counting in a hemocytometer after
initial seeding of 104 cells from each MSC population. Relative proliferative capacity was calculated as fold changes after setting the initial cell number 104
cells = 1. Likewise, a second reculture after repeated cryopreservation of these UC tissue pieces (MSC100314UC-re(2), MSC110314UC-re(2), MSC180314UC-re(2))
demonstrated similar cell growth properties compared with the previous explant culture of the same tissues under the same experimental conditions. Data
represent the mean ± SD of three independent experiments. Statistical analysis was performed by Student’s t test (**p <0.001). b A parallel cell cycle analysis
of the MSC explant cultures was performed by flow cytometry and demonstrated proliferating cells in all cultures by the appearance of
all cell cycle phases in the histograms. c Detection of senescent cells in MSCUC-re(2) explant culture by SA-β-gal staining. Staining of outgrowing MSC-like
cells (MSC100314UC-re(2), MSC110314UC-re(2), MSC180314UC-re(2)) obtained from the repeated reculture of a second corresponding tissue
cryopreservation with the SA-β-gal kit demonstrated only a marginal expression of this aging marker (arrows) in less than 2 % of the cells.
SA-β-gal senescence-associated β-galactosidase
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during explant culture would last about 2–3 weeks,
and thereafter continuous explant culture of these tis-
sue pieces from the whole UC could yield a total
amount of more than 1010 MSC within 4 weeks.
Moreover, these cells can be subcultured from each
explant culture in various distinct passages to further
potentiate the number of MSC.
During consecutive freeze/thaw/explant culture cycles,
potential stem cell aging was quantified by the SA-β-gal
assay. Whereas low levels of SA-β-gal-positive cells were
observed in MSCUC-re(1) as 2.8 ± 1.3 % and in MSCUC-re(4)
cultures as 3.9 ± 0.3 %, these numbers progressively and
significantly increased in populations of MSCUC-re(7) to
7.8 ± 3.3 % and in MSCUC-re(10) to 15.3 ± 0.5 % (Fig. 7d).
Together, these findings suggested that the reduced prolif-
erative capacity of MSC derived from 10 freeze/thaw/ex-
plant culture cycles correlated with significantly elevated
amount of SA-β-gal-positive cells.
In order to address a potentially preferred homing of
MSC to UC tissue rather than plastic, UC270815 tissue
(96.3 ± 50.1 mg/tissue; n = 4) was cocultured with
MSC100314GFP (1000 cells/cm2) in four separate experi-
ments, whereby the original outgrowth of cells from
these tissues had stopped. This coculture was performed
on plastic in 24-well plates (Nunc) and cell growth was
compared with a corresponding MSC monoculture at
the same experimental conditions. After 6 days of cul-
ture, the UC tissue and the additional cells in the well
and also the monoculture cells were lysed by SDS and
aliquots were measured for fluorescence intensities and
calculated to the appropriate amount of cells. Whereas
6.65 ± 0.48 × 104 MSCGFP were detected in the monocul-
ture, the coculture was associated with 5.51 ± 0.62 × 104
MSCGFP attached to the plastic in the well and an add-
itional 2.26 × 104 MSCGFP were associated with the UC
tissue (Fig. 8). These findings suggested enhanced cell
growth in the presence of UC tissue and a preferred
localization of MSCGFP in the UC tissue since the
amount of MSC plastic adherence in the UC tissue co-
culture was markedly lower as compared with the MSC
plastic adherence in the monoculture. Indeed, a fluores-
cence micrograph confirmed incorporation of MSCGFP
into the rim of the UC tissue (Fig. 8). Additional prelim-
inary observations were obtained following three exten-
sive washes with PBS and further culture of the
MSCGFP-incorporated UC tissue (61.6 mg) in a separate
new well for 7 days, which was associated with a signifi-
cantly enhanced proliferation reaching 1.2 × 105 MSCGFP
within the tissue similar to a conditioning of the tissue.
Moreover, about 103 cells were detected as explant cul-
ture from this tissue. These preliminary findings were
substantiated by a fluorescence micrograph demonstrat-
ing the whole UC tissue filled with MSCGFP and add-
itional outgrowth of some cells (data not shown) which
indicated conditioning of the UC tissue.
Discussion
Multipotent human MSC represent a preferred tool for
cell or tissue replacement therapy and are involved in a
large variety of clinical studies in regenerative medicine.
Fig. 5 MSC surface marker analysis. Cell surface marker evaluation was performed for the presence of the typical MSC markers (CD73, CD90, and
CD105) by flow cytometry analysis in cells of three individual UC explant cultures of the previously cryopreserved UC tissues. a MSC100314UC-re(1).
b MSC110314UC-re(1). c MSC180314UC-re(1). Moreover, the MSC marker expression was compared with cells obtained after second reculture
following repeated cryopreservation of these UC tissue pieces. d MSC100314UC-re(2). e MSC110314UC-re(2). f MSC180314UC-re(2). A simultaneous absence
of further cell type-specific surface markers CD31, CD34, CD45, and CD14 was tested. The analysis was performed in steady state-growing cells by flow
cytometry compared with the corresponding immunoglobulin isotype antibodies which were used as appropriate controls in the histograms. MSC
mesenchymal stroma/stem cells
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To meet the progressively increasing requirement of
MSC as a more frequently used stem cell population in
tissue engineering, UC provides a noninvasive, easily ac-
cessible, and ethically noncontroversial MSC-rich stem
cell source [4]. Moreover, cryostorage of MSC-
originating tissue significantly elevates the availability of
reproducible material and potential cryoconditions for
tissues and other biospecimens have been tested previ-
ously [28]. Accordingly, cryopreservation of conditioned
UC tissue in liquid nitrogen demonstrated a constant
availability of MSC with reproducible properties includ-
ing proliferative capacity, the maintenance of certain
plasticity, and stable stem cell characteristics.
All MSC obtained after reculture of previously cryo-
preserved UC tissues from various donors demonstrated
at least differentiation capacity along mesodermal line-
ages, including acquisition of osteogenic, adipogenic,
and chondrogenic properties. Moreover, UC tissue and
the corresponding explant cultures expressed CD73,
CD90, and CD105, representing the minimal criteria for
MSC markers. Previous work demonstrated that some
MSC subpopulations also carry STRO-1 [29], or the re-
ceptors vascular cell adhesion molecule-1 (VCAM-1,
CD106) and intercellular cell adhesion molecule-1
(ICAM-1, CD54) [30] preferably expressed in bone
marrow-derived MSC. In addition, octamer-binding
transcription factor-4 (OCT-4) and (sex determining re-
gion Y)-box-2 (SOX2) as embryonic-like stem cell
markers can be detected in certain MSC subpopulations
[31], further substantiating MSC heterogeneity and
Fig. 6 Differentiation capacity of conditioned UC tissue explant cultures. After thawing and reculture of three conditioned cryopreserved UC
tissues as well as second thawing and repeated reculture (MSC100314UC-re(2)) of previously cryopreserved UC tissue, the resulting MSC explant
cultures were investigated for their potential to differentiate along the osteogenic, adipogenic, and chondrogenic pathway. All explant cultures
when maintained in appropriate differentiation medium demonstrated strong Alizarin red staining which indicated increased calcification during
osteogenesis in contrast to MSC control cultures maintained in normal growth medium. Moreover, the appearance of lipid droplets in the
cultures as indicated by oil red O staining (yellow arrowheads) revealed adipogenic properties. Finally, enhanced production of proteoglycans
within the extracellular matrix represents a property of chondrogenic cells which was detectable by alcian blue staining of differentiated MSC in
contrast to corresponding control cells
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plasticity by the appearance, acquisition, or loss of dis-
tinct properties. Furthermore, MSC contribute to a
transfer and exchange of markers with neighboring tis-
sue cells, thereby altering cellular functionality by en-
hanced plasticity [25, 32, 33].
Conditioning of UC tissue prior to cryopreservation by
initial culture for about 2–3 weeks demonstrated prolif-
eration of cells within the tissue to reach certain intratis-
sue saturation. This was followed by active outgrowth of
cells carrying typical MSC markers during explant
culture.
Different isolation protocols to obtain MSC from UC
tissue include enzymatic digestion of the extracellular
matrix by either trypsin, collagenase, or accutase treat-
ment, in contrast to another technique which is keeping
an intact and physiological extracellular matrix by ex-
plant culture of MSC from UC tissue pieces. Whereas
certain results favor enzymatic tissue treatment [34],
other studies demonstrated an advantage of MSC ex-
plant culture [35]. However, differences in MSC culture
conditions including various media and, more import-
antly, the use of poorly defined additives such as FCS
Fig. 7 Characterization of MSCs after repeated freeze/thaw/explant cultures. a MSC marker expression in repeated freeze/thaw/explant cultures.
Conditioned UC tissue after initial explant culture was subjected to 10 cycles of freeze/thaw/explant culture and cell cultures obtained from each
cycle were harvested and analyzed by RT-PCR for the expression of the MSC markers CD73, CD90, and CD105 with GAPDH expression as a control. The
cumulative yield of MSC from each freeze/thaw/explant culture cycle was calculated for a 10-day period. b Conditioned UC tissue after initial explant
culture was subjected to one, four, seven, and 10 freeze/thaw/explant culture cycles, respectively, and cell surface marker analysis was performed for the
presence of the typical MSC markers (CD73, CD90, and CD105) by flow cytometry. c Proliferative capacity of MSC-like cells obtained after reculture of
cryopreserved conditioned UC tissues from one, four, seven, and 10 freeze/thaw/explant culture cycles was evaluated by cell counting in a hemocytometer
after initial seeding of 104 cells from each MSC population. Relative proliferative capacity was calculated as fold changes after setting the initial cell number
104 cells = 1. Data represent the mean ± SD of four independent experiments. Statistical analysis was performed by Student’s t test. d Conditioned UC tissue
after initial explant culture was subjected to one, four, seven, and 10 freeze/thaw/explant culture cycles, respectively, and the SA-β-gal assay was applied to
the outgrowing MSC cultures. SA-β-gal-positive cells were quantified as mean ± SD of three independent experiments. Statistical analysis was performed
by Student’s t test. bp base pairs, MSC mesenchymal stroma/stem cells, PE phycoerythrin, UC umbilical cord
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instead of xeno-free components further contribute to
heterogeneity of the data.
Previous work has suggested that the enzyme-free ex-
plant culture ensures the maintenance of an intact
microenvironment within the tissue pieces to keep a nat-
ural three-dimensional stroma structure for MSC with
appropriate surface interaction sites [5]. Interestingly,
this MSC-like outgrowth during explant culture was
significantly accelerated after reculture of cryopreserved
conditioned UC tissue when the UC tissue structure
became more condensed by contracting forces. Other
studies observed a gradient of cell maturity within the
UC tissues [36] and considered the cytoskeletal com-
plexity in UC tissue, which supports the idea of a
location-dependent and microenvironment-dependent
growth and differentiation potential of UC-derived
MSC [36, 37].
In addition to the results of the UC tissues in this
study, storage of MSC cultures can also be performed by
cryopreservation in liquid nitrogen [38]. However, sub-
culture of MSCs is associated with limited expansion
until approximately 10 passages [5, 39]. Similar findings
were obtained during repeated freeze/thaw/explant cul-
ture cycles whereby reduced proliferative capacity after
10 cycles was accompanied by elevated senescence in
the culture as determined by an increased amount of
SA-β-gal-positive cells. In addition, previous work has
demonstrated prolonged culture of MSC by keeping the
originating UC tissue structure to provide a more
physiological three-dimensional microenvironment for
explant culture [5]. Indeed, the comparison of MSC cul-
ture on plastic versus UC tissue demonstrated a pre-
ferred homing of MSC to UC tissue.
Conclusion
In summary, these findings suggested that maintenance
of MSC in a three-dimensional culture enables the es-
tablishment of a natural microenvironment providing
long-term outgrowth potential of stem cell-like cells
with unchanged growth properties for at least four
freeze/thaw/explant culture cycles. Moreover, repeated
cryopreservation of conditioned UC tissues keeps
stroma/stem cell multiplicity and thereby minimizes a
likely culture condition-mediated clonal selection or
progressive clonal convergence towards an accumulation
of certain subpopulations. Consequently, these tissues
provide a microenvironment for maximal plasticity
with reasonable amounts of originating MSC which is
required in the field of regenerative medicine. More-
over, this more natural three-dimensional stem cell
culture also enables UC tissue banking with reprodu-
cible availability of MSC for cell therapies and tissue
engineering.
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